Blood Vessel Inhibitor Shows Promise Against Metastatic Thyroid Cancer

July 04th, 2008 | Category: Cancer

Thyroid cancer that has spread to distant sites has a poor prognosis, but an experimental drug that inhibits tumor blood vessel formation can slow disease progression in some patients, a research team led by investigators from

The University of Texas M. D. Anderson Cancer Center reports in the July 3rd edition of The New England Journal of Medicine.

Original post by Women’s Health / Gynecology News From Medical News Today

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Netvouz
  • DZone
  • ThisNext
  • MisterWong
  • Wists
  • BlinkList
  • Furl
  • IndianPad
  • Netscape
  • Reddit
  • Simpy
  • Spurl
  • StumbleUpon
  • Technorati
Related Articles
  • Advanced Thyroid Cancer Investigational Drug Shows Promise
  • Iressa Shows Promise For Treatment Of Metastatic Breast Cancer When Combined With Hormonal Therapy
  • Increase In Cases Of Thyroid Cancer May Be Due To Better Detection
  • Kosan’s Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit In Phase 1 HER2-Positive Metastatic Breast Cancer Trial
  • Study Shows Coronado Biosciences’ Bcl-2 Inhibitor, Apogossypol, Is More Efficacious, Less Toxic Than Gossypol In Animal Models

    • No comments yet. Be the first.

    Leave a reply